Dr Alicia Chenoweth received her BSc and Hons in Biomedical Science from the University of Adelaide (2012). She studied her PhD under the supervision of Prof. Mark Hogarth at the Burnet Institute and Monash University in Melbourne, Australia. Her work focused on the interactions of human and non-human primate IgG antibodies with Fc receptors and the impact of IgG Fc modification on immune cell function. She received her PhD in 2018 and then moved to King's College London as a postdoctoral Research Associate in the Cancer Antibody Discovery and Immunotherapy group led by Prof. Sophia Karagiannis, funded by Breast Cancer Now.

Alicia's research interests include antibody engineering and its effect on immune cell function in the context of breast cancer therapy.